Why Bristol-Myers Squibb (BMY) is a Great Dividend Stock Right NowZacks Investment Research • 05/18/20
Bristol Myers Squibb Receives a 'Refuse to File' Letter for an Experimental Cancer Therapy on a DeadlineThe Motley Fool • 05/13/20
The No. 1 Pharma Stock Just Crushed Earnings Views — Is BMY Stock A Buy?Investors Business Daily • 05/08/20
3 Big Stock Charts for Friday: Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKlineInvestorPlace • 05/08/20